(+)-epicatechin-3-O-gallate multiple interactions ISO RGD:733618 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of DNM1L protein] CTD PMID:29061316 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:733618 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of DNM1L protein] CTD PMID:29061316 (S)-nicotine increases expression ISO RGD:733618 6480464 Nicotine results in increased expression of DNM1L protein CTD PMID:21554491 17alpha-ethynylestradiol affects expression ISO RGD:733619 6480464 Ethinyl Estradiol affects the expression of DNM1L mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:733619 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNM1L mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:733619 6480464 Ethinyl Estradiol results in increased expression of DNM1L mRNA CTD PMID:17942748 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:733618 6480464 Dihydrotestosterone results in increased expression of DNM1L mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:733619 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733618 6480464 [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of DNM1L mRNA CTD PMID:19684285 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733619 6480464 Tetrachlorodibenzodioxin affects the expression of DNM1L mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of DNM1L mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733619 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNM1L mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733619 6480464 Tetrachlorodibenzodioxin results in increased expression of DNM1L mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733618 6480464 Tetrachlorodibenzodioxin results in increased expression of DNM1L mRNA CTD PMID:19684285 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of DNM1L mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of DNM1L mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:733618 6480464 beta-methylcholine affects the expression of DNM1L mRNA CTD PMID:21179406 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:733619 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of DNM1L mRNA CTD PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733618 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DNM1L mRNA CTD PMID:28628672 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733619 6480464 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in decreased expression of DNM1L mRNA, [rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in decreased expression of DNM1L mRNA CTD PMID:29288687 4,4'-diaminodiphenylmethane increases expression ISO RGD:733619 6480464 4, 4'-diaminodiphenylmethane results in increased expression of DNM1L mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of DNM1L protein CTD PMID:31344369 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of DNM1L mRNA CTD PMID:21346803 4-DAMP(1+) increases phosphorylation EXP 6480464 4-diphenylacetoxy-1, 1-dimethylpiperidinium results in increased phosphorylation of DNM1L protein CTD PMID:27491814 4-vinylcyclohexene dioxide affects expression ISO RGD:733619 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of DNM1L mRNA CTD PMID:20829426 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of DNM1L mRNA CTD PMID:24780913 acetylleucyl-leucyl-norleucinal multiple interactions ISO RGD:733619 6480464 acetylleucyl-leucyl-norleucinal inhibits the reaction [ferric ammonium citrate results in decreased phosphorylation of DNM1L protein] CTD PMID:27481217 aflatoxin B1 increases methylation ISO RGD:733618 6480464 Aflatoxin B1 results in increased methylation of DNM1L intron CTD PMID:30157460 aflatoxin B2 increases methylation ISO RGD:733618 6480464 aflatoxin B2 results in increased methylation of DNM1L intron CTD PMID:30157460 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of DNM1L protein CTD PMID:27684054 , PMID:30144576 aldehydo-D-glucose multiple interactions EXP 6480464 cinnamic acid inhibits the reaction [Glucose results in increased expression of DNM1L protein], Metformin inhibits the reaction [Glucose results in increased expression of DNM1L protein] CTD PMID:30144576 alpha-D-galactose multiple interactions ISO RGD:733618 6480464 MIR34A mRNA promotes the reaction [Galactose results in increased expression of DNM1L protein] CTD PMID:28302704 alpha-D-galactose increases expression EXP 6480464 Galactose results in increased expression of DNM1L protein CTD PMID:28302704 alpha-D-galactose increases expression ISO RGD:733618 6480464 Galactose results in increased expression of DNM1L protein CTD PMID:28302704 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of DNM1L mRNA CTD PMID:16483693 Aroclor 1254 decreases expression ISO RGD:733619 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of DNM1L mRNA CTD PMID:23650126 arsenous acid multiple interactions ISO RGD:733619 6480464 ATF4 protein promotes the reaction [Arsenic Trioxide affects the expression of DRP1 protein modified form], salvianolic acid A inhibits the reaction [Arsenic Trioxide results in decreased expression of DNM1L protein] CTD PMID:27638049 , PMID:29867492 arsenous acid decreases expression ISO RGD:733619 6480464 Arsenic Trioxide results in decreased expression of DNM1L protein CTD PMID:29867492 arsenous acid affects expression ISO RGD:733619 6480464 Arsenic Trioxide affects the expression of DRP1 protein modified form CTD PMID:27638049 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of DNM1L protein CTD PMID:29867492 arsenous acid multiple interactions EXP 6480464 salvianolic acid A inhibits the reaction [Arsenic Trioxide results in decreased expression of DNM1L protein] CTD PMID:29867492 azide multiple interactions EXP 6480464 DNM1L protein promotes the reaction [Azides affects the localization of AIFM1 protein], DNM1L protein promotes the reaction [Azides results in increased activity of BAX protein] CTD PMID:21160028 azide increases response to substance ISO RGD:733618 6480464 DNM1L protein results in increased susceptibility to Azides CTD PMID:21160028 azide increases response to substance EXP 6480464 DNM1L protein results in increased susceptibility to Azides CTD PMID:21160028 azide multiple interactions ISO RGD:733618 6480464 DNM1L protein promotes the reaction [Azides results in increased activity of BAX protein] CTD PMID:21160028 benzo[a]pyrene increases expression ISO RGD:733619 6480464 Benzo(a)pyrene results in increased expression of DNM1L mRNA CTD PMID:22228805 benzo[a]pyrene affects methylation ISO RGD:733618 6480464 Benzo(a)pyrene affects the methylation of DNM1L intron CTD PMID:30157460 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DNM1L mRNA CTD PMID:18164116 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:733619 6480464 Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate affects the localization of DNM1L protein] more ... CTD PMID:31408635 bis(2-ethylhexyl) phthalate affects localization ISO RGD:733619 6480464 Diethylhexyl Phthalate affects the localization of DNM1L protein CTD PMID:31408635 bisphenol A multiple interactions ISO RGD:733618 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DNM1L mRNA CTD PMID:28628672 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of DNM1L protein CTD PMID:31344369 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of DNM1L mRNA CTD PMID:19167457 CCCP multiple interactions ISO RGD:733618 6480464 DNM1L protein promotes the reaction [Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased expression of CASP3 protein modified form], DNM1L protein promotes the reaction [Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased expression of CASP9 protein modified form] CTD PMID:29241732 CCCP decreases expression ISO RGD:733618 6480464 Carbonyl Cyanide m-Chlorophenyl Hydrazone results in decreased expression of DNM1L protein modified form CTD PMID:28940366 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of DNM1L mRNA CTD PMID:20691718 cinnamic acid multiple interactions EXP 6480464 cinnamic acid inhibits the reaction [Glucose results in increased expression of DNM1L protein] CTD PMID:30144576 cisplatin increases response to substance ISO RGD:733618 6480464 DNM1L protein results in increased susceptibility to Cisplatin CTD PMID:21160028 cisplatin increases expression ISO RGD:733619 6480464 Cisplatin results in increased expression of DNM1L mRNA CTD PMID:21151649 cocaine increases phosphorylation ISO RGD:733619 6480464 Cocaine results in increased phosphorylation of DNM1L protein CTD PMID:31494168 cocaine multiple interactions EXP 6480464 [Cocaine co-treated with Cocaine deficiency] promotes the reaction [RUNX2 protein binds to DNM1L promoter] CTD PMID:30158054 Colforsin dapropate hydrochloride multiple interactions ISO RGD:733618 6480464 PINK1 protein affects the reaction [Colforsin results in decreased expression of DNM1L protein] CTD PMID:24792327 Colforsin dapropate hydrochloride decreases expression ISO RGD:733618 6480464 Colforsin results in decreased expression of DNM1L protein CTD PMID:24792327 coumestrol multiple interactions ISO RGD:733618 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNM1L mRNA CTD PMID:19167446 cycloheximide increases expression ISO RGD:733618 6480464 Cycloheximide results in increased expression of DNM1L mRNA CTD PMID:19684285 cycloheximide multiple interactions ISO RGD:733618 6480464 [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of DNM1L mRNA CTD PMID:19684285 cyclosporin A increases expression ISO RGD:733618 6480464 Cyclosporine results in increased expression of DNM1L mRNA CTD PMID:25562108 cyclosporin A multiple interactions ISO RGD:733619 6480464 Cyclosporine inhibits the reaction [ferric ammonium citrate results in decreased phosphorylation of DNM1L protein] CTD PMID:26318285 D-glucose increases expression EXP 6480464 Glucose results in increased expression of DNM1L protein CTD PMID:27684054 , PMID:30144576 D-glucose multiple interactions EXP 6480464 cinnamic acid inhibits the reaction [Glucose results in increased expression of DNM1L protein], Metformin inhibits the reaction [Glucose results in increased expression of DNM1L protein] CTD PMID:30144576 desferrioxamine B multiple interactions ISO RGD:733619 6480464 Deferoxamine inhibits the reaction [ferric ammonium citrate results in decreased phosphorylation of DNM1L protein] CTD PMID:26318285 dexamethasone multiple interactions ISO RGD:733618 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DNM1L mRNA CTD PMID:28628672 dexamethasone multiple interactions ISO RGD:733619 6480464 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in decreased expression of DNM1L mRNA, [rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in decreased expression of DNM1L mRNA CTD PMID:29288687 diarsenic trioxide multiple interactions ISO RGD:733619 6480464 ATF4 protein promotes the reaction [Arsenic Trioxide affects the expression of DRP1 protein modified form], salvianolic acid A inhibits the reaction [Arsenic Trioxide results in decreased expression of DNM1L protein] CTD PMID:27638049 , PMID:29867492 diarsenic trioxide affects expression ISO RGD:733619 6480464 Arsenic Trioxide affects the expression of DRP1 protein modified form CTD PMID:27638049 diarsenic trioxide multiple interactions EXP 6480464 salvianolic acid A inhibits the reaction [Arsenic Trioxide results in decreased expression of DNM1L protein] CTD PMID:29867492 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of DNM1L protein CTD PMID:29867492 diarsenic trioxide decreases expression ISO RGD:733619 6480464 Arsenic Trioxide results in decreased expression of DNM1L protein CTD PMID:29867492 dicrotophos decreases expression ISO RGD:733618 6480464 dicrotophos results in decreased expression of DNM1L mRNA CTD PMID:28302478 dioxygen multiple interactions ISO RGD:733619 6480464 [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of DNM1L protein, genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of DNM1L protein] CTD PMID:28477916 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of DNM1L protein CTD PMID:25911325 , PMID:27684054 dioxygen multiple interactions EXP 6480464 [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased susceptibility to 6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-N-(2 more ... CTD PMID:25911325 more ... dorsomorphin increases phosphorylation EXP 6480464 dorsomorphin results in increased phosphorylation of DNM1L protein CTD PMID:27491814 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of DNM1L protein CTD PMID:29966675 doxorubicin increases expression ISO RGD:733618 6480464 Doxorubicin results in increased expression of DNM1L protein CTD PMID:29729358 doxorubicin increases phosphorylation EXP 6480464 Doxorubicin results in increased phosphorylation of DNM1L protein CTD PMID:30831132 doxorubicin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Doxorubicin results in increased expression of DNM1L protein] more ... CTD PMID:29966675 , PMID:30831132 efavirenz affects localization ISO RGD:733618 6480464 efavirenz affects the localization of DNM1L protein modified form CTD PMID:28940366 Enterolactone multiple interactions ISO RGD:733618 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNM1L mRNA CTD PMID:19167446 enzyme inhibitor multiple interactions ISO RGD:733618 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DNM1L protein CTD PMID:23301498 ethanol multiple interactions ISO RGD:733619 6480464 Ethanol affects the expression of and affects the splicing of DNM1L mRNA CTD PMID:30319688 excitatory amino acid agonist decreases expression EXP 6480464 Excitatory Amino Acid Agonists results in decreased expression of DNM1L protein CTD PMID:25416777 excitatory amino acid agonist multiple interactions EXP 6480464 Dizocilpine Maleate inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of DNM1L protein] CTD PMID:25416777 ferric ammonium citrate decreases phosphorylation ISO RGD:733619 6480464 ferric ammonium citrate results in decreased phosphorylation of DNM1L protein CTD PMID:27481217 ferric ammonium citrate multiple interactions ISO RGD:733619 6480464 1 more ... CTD PMID:26318285 , PMID:27481217 ferulic acid multiple interactions EXP 6480464 ferulic acid inhibits the reaction [Streptozocin results in increased expression of DNM1L protein] CTD PMID:31029786 galactose increases expression EXP 6480464 Galactose results in increased expression of DNM1L protein CTD PMID:28302704 galactose multiple interactions ISO RGD:733618 6480464 MIR34A mRNA promotes the reaction [Galactose results in increased expression of DNM1L protein] CTD PMID:28302704 galactose increases expression ISO RGD:733618 6480464 Galactose results in increased expression of DNM1L protein CTD PMID:28302704 gallic acid multiple interactions ISO RGD:733618 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of DNM1L protein] CTD PMID:29061316 gallocatechin multiple interactions ISO RGD:733618 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of DNM1L protein] CTD PMID:29061316 Genipin multiple interactions ISO RGD:733619 6480464 genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of DNM1L protein] CTD PMID:28477916 glucose increases expression EXP 6480464 Glucose results in increased expression of DNM1L protein CTD PMID:27684054 , PMID:30144576 glucose multiple interactions EXP 6480464 cinnamic acid inhibits the reaction [Glucose results in increased expression of DNM1L protein], Metformin inhibits the reaction [Glucose results in increased expression of DNM1L protein] CTD PMID:30144576 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of DNM1L mRNA CTD PMID:24395379 hydrogen peroxide affects expression ISO RGD:733618 6480464 Hydrogen Peroxide affects the expression of DNM1L mRNA CTD PMID:21179406 hydrogen peroxide multiple interactions ISO RGD:733618 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of DNM1L protein] more ... CTD PMID:29061316 , PMID:30316844 hydrogen peroxide decreases expression ISO RGD:733618 6480464 Hydrogen Peroxide results in decreased expression of DNM1L mRNA, Hydrogen Peroxide results in decreased expression of DNM1L protein CTD PMID:29061316 , PMID:30316844 indometacin multiple interactions ISO RGD:733618 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DNM1L mRNA CTD PMID:28628672 isoprenaline increases phosphorylation EXP 6480464 Isoproterenol results in increased phosphorylation of DNM1L protein CTD PMID:27491814 Licarin A multiple interactions ISO RGD:733619 6480464 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in decreased expression of DNM1L mRNA CTD PMID:29288687 mabuterol multiple interactions EXP 6480464 [mabuterol co-treated with 3-(2 more ... CTD PMID:31009640 mangiferin multiple interactions ISO RGD:733618 6480464 mangiferin inhibits the reaction [Methylmercury Compounds results in increased expression of and results in increased phosphorylation of DNM1L protein] CTD PMID:28071871 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Carbon Tetrachloride results in decreased expression of DNM1L protein], Melatonin inhibits the reaction [Doxorubicin results in increased expression of DNM1L protein] CTD PMID:26882442 , PMID:29966675 melatonin multiple interactions ISO RGD:733618 6480464 Melatonin inhibits the reaction [Rotenone results in increased expression of DNM1L protein] CTD PMID:29183837 menadione affects expression ISO RGD:733619 6480464 Vitamin K 3 affects the expression of DNM1L mRNA CTD PMID:20829426 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [Glucose results in increased expression of DNM1L protein] CTD PMID:30144576 methoxychlor affects expression ISO RGD:733619 6480464 Methoxychlor affects the expression of DNM1L mRNA CTD PMID:20829426 N-(4-aminobutyl)-5-chloronaphthalene-2-sulfonamide multiple interactions ISO RGD:733619 6480464 N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide inhibits the reaction [ferric ammonium citrate results in decreased phosphorylation of DNM1L protein] CTD PMID:27481217 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [15-deoxyprostaglandin J2 affects the reaction [DNM1L protein binds to DNM1L protein binds to DNM1L protein binds to DNM1L protein]] CTD PMID:20307494 N-acetyl-L-cysteine multiple interactions ISO RGD:733619 6480464 Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate affects the localization of DNM1L protein], Acetylcysteine inhibits the reaction [Diethylhexyl Phthalate results in increased expression of and affects the phosphorylation of DNM1L protein] CTD PMID:31408635 N-acetylsphingosine increases expression EXP 6480464 N-acetylsphingosine results in increased expression of DNM1L protein CTD PMID:18006463 N-methyl-4-phenylpyridinium increases expression ISO RGD:733618 6480464 1-Methyl-4-phenylpyridinium results in increased expression of DNM1L CTD PMID:21615675 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of DNM1L mRNA CTD PMID:18164116 nicotine increases expression ISO RGD:733618 6480464 Nicotine results in increased expression of DNM1L protein CTD PMID:21554491 okadaic acid increases phosphorylation EXP 6480464 Okadaic Acid results in increased phosphorylation of DNM1L protein CTD PMID:26732598 oxidopamine multiple interactions ISO RGD:733618 6480464 3-(2, 4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Oxidopamine affects the localization of DNM1L protein] CTD PMID:22821850 oxidopamine affects localization ISO RGD:733618 6480464 Oxidopamine affects the localization of DNM1L protein CTD PMID:22821850 paracetamol increases expression ISO RGD:733618 6480464 Acetaminophen results in increased expression of DNM1L mRNA CTD PMID:25704631 paracetamol increases expression ISO RGD:733619 6480464 Acetaminophen results in increased expression of DNM1L protein CTD PMID:28827156 paraquat increases expression ISO RGD:733618 6480464 Paraquat results in increased expression of DNM1L protein CTD PMID:28215578 paraquat increases expression ISO RGD:733619 6480464 Paraquat results in increased expression of DNM1L protein CTD PMID:28215578 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:733619 6480464 perfluorooctane sulfonic acid results in decreased expression of DNM1L protein CTD PMID:26178269 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of DNM1L protein CTD PMID:20886221 phenylephrine multiple interactions EXP 6480464 CAT protein inhibits the reaction [Phenylephrine results in increased expression of DNM1L protein] more ... CTD PMID:20886221 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of DNM1L mRNA CTD PMID:19162173 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [Rotenone results in decreased expression of DNM1L mRNA], resveratrol inhibits the reaction [Rotenone results in decreased expression of DNM1L protein] CTD PMID:26770656 rotenone decreases expression ISO RGD:733619 6480464 Rotenone results in decreased expression of DNM1L mRNA CTD PMID:23186747 rotenone increases expression ISO RGD:733618 6480464 Rotenone results in increased expression of DNM1L protein CTD PMID:29183837 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of DNM1L mRNA, Rotenone results in decreased expression of DNM1L protein CTD PMID:26770656 rotenone multiple interactions ISO RGD:733618 6480464 Melatonin inhibits the reaction [Rotenone results in increased expression of DNM1L protein], Rotenone results in increased expression of and results in increased phosphorylation of DNM1L protein CTD PMID:28071871 , PMID:29183837 rotenone multiple interactions EXP 6480464 Resveratrol inhibits the reaction [Rotenone results in decreased expression of DNM1L mRNA] more ... CTD PMID:26770656 , PMID:28526446 rotenone increases expression EXP 6480464 Rotenone results in increased expression of DNM1L protein CTD PMID:28526446 Salvianolic acid A multiple interactions ISO RGD:733619 6480464 salvianolic acid A inhibits the reaction [Arsenic Trioxide results in decreased expression of DNM1L protein] CTD PMID:29867492 Salvianolic acid A multiple interactions EXP 6480464 salvianolic acid A inhibits the reaction [Arsenic Trioxide results in decreased expression of DNM1L protein] CTD PMID:29867492 SB-239063 multiple interactions EXP 6480464 [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased susceptibility to SB 239063] which results in decreased expression of DNM1L protein CTD PMID:26116440 sevoflurane multiple interactions EXP 6480464 sevoflurane inhibits the reaction [Oxygen deficiency results in increased expression of DNM1L protein] CTD PMID:27684054 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of DNM1L mRNA CTD PMID:31034866 simvastatin affects localization ISO RGD:733618 6480464 Simvastatin affects the localization of DNM1L protein CTD PMID:20045437 simvastatin increases expression ISO RGD:733618 6480464 Simvastatin results in increased expression of DNM1L protein CTD PMID:20045437 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of DNM1L protein CTD PMID:29459688 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of DNM1L mRNA CTD PMID:22561333 streptozocin multiple interactions EXP 6480464 ferulic acid inhibits the reaction [Streptozocin results in increased expression of DNM1L protein] CTD PMID:31029786 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of DNM1L protein CTD PMID:31029786 sulforaphane increases expression ISO RGD:733618 6480464 sulforafan results in increased expression of DNM1L protein alternative form CTD PMID:27993529 tacrolimus hydrate multiple interactions ISO RGD:733618 6480464 PINK1 protein affects the reaction [Tacrolimus results in increased phosphorylation of DNM1L protein] CTD PMID:19492085 tacrolimus hydrate multiple interactions ISO RGD:733619 6480464 Tacrolimus inhibits the reaction [ferric ammonium citrate results in decreased phosphorylation of DNM1L protein] CTD PMID:26318285 tamoxifen affects expression ISO RGD:733619 6480464 Tamoxifen affects the expression of DNM1L mRNA CTD PMID:17555576 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of DNM1L protein CTD PMID:26882442 tetrachloromethane increases expression ISO RGD:733619 6480464 Carbon Tetrachloride results in increased expression of DNM1L protein CTD PMID:30368983 tetrachloromethane multiple interactions ISO RGD:733619 6480464 SIRT3 protein affects the reaction [Carbon Tetrachloride results in increased expression of DNM1L protein] CTD PMID:30368983 tetrachloromethane multiple interactions EXP 6480464 Melatonin inhibits the reaction [Carbon Tetrachloride results in decreased expression of DNM1L protein] CTD PMID:26882442 thapsigargin increases expression ISO RGD:733618 6480464 Thapsigargin results in increased expression of DNM1L mRNA CTD PMID:28940366 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of DNM1L mRNA CTD PMID:23411599 trans-cinnamic acid multiple interactions EXP 6480464 cinnamic acid inhibits the reaction [Glucose results in increased expression of DNM1L protein] CTD PMID:30144576 trifloxystrobin increases phosphorylation ISO RGD:733618 6480464 trifloxystrobin results in increased phosphorylation of DNM1L protein CTD PMID:27853101 trifloxystrobin multiple interactions ISO RGD:733618 6480464 MitoTEMPO inhibits the reaction [trifloxystrobin results in increased phosphorylation of DNM1L protein] CTD PMID:27853101 Triptolide multiple interactions ISO RGD:733619 6480464 10-(6'-ubiquinonyl)decyltriphenylphosphonium bromide inhibits the reaction [triptolide results in decreased expression of DNM1L protein] CTD PMID:30836114 Triptolide decreases expression ISO RGD:733619 6480464 triptolide results in decreased expression of DNM1L protein CTD PMID:30836114 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of DNM1L mRNA CTD PMID:20566332 zearalenone multiple interactions ISO RGD:733619 6480464 [Zearalenone co-treated with CGA protein] results in increased expression of DNM1L protein CTD PMID:25058043 zidovudine multiple interactions ISO RGD:733618 6480464 [DTYMK protein affects the susceptibility to Zidovudine] which affects the expression of and affects the phosphorylation of DNM1L protein more ... CTD PMID:28683400 zidovudine affects localization EXP 6480464 Zidovudine affects the localization of DNM1L protein CTD PMID:28683400
Biological Process apoptotic mitochondrial changes IBA PANTHER:PTN002480309 more ... 13792537 PMID:21873635 GO_Central calcium ion transport ISO RGD:733619 1624291 MGI:MGI:5312923 (MGI:MGI:6142037 , PMID:28063983) RGD MGI:MGI:6142037 , PMID:28063983 cellular response to lipid IEP 12738362 C2-ceramide RGD cellular response to oxygen-glucose deprivation IEP 12738215 RGD cellular response to thapsigargin IMP 12738363 RGD dynamin family protein polymerization involved in mitochondrial fission ISO RGD:733618 1624291 (PMID:11514614), (PMID:23530241) RGD PMID:11514614 , PMID:23530241 dynamin family protein polymerization involved in mitochondrial fission ISS UniProtKB:O00429 1600115 GO_REF:0000024 UniProt GO_REF:0000024 endoplasmic reticulum organization NOT ISO RGD:733618 1624291 (PMID:11514614) RGD PMID:11514614 heart contraction ISO RGD:733619 1624291 (MGI:MGI:4459561, PMID:20585624) RGD MGI:MGI:4459561 , PMID:20585624 intracellular distribution of mitochondria IMP 7800727 RGD intracellular distribution of mitochondria IBA PANTHER:PTN002480309 more ... 13792537 PMID:21873635 GO_Central intracellular distribution of mitochondria ISO RGD:733618 1624291 (PMID:11514614) RGD PMID:11514614 membrane fusion ISO RGD:733618 1624291 (PMID:20850011) RGD PMID:20850011 mitochondrial fission ISO RGD:733619 1624291 (MGI:MGI:4421613 more ... RGD MGI:MGI:4421613 more ... mitochondrial fission ISS UniProtKB:Q8K1M6 1600115 GO_REF:0000024 UniProt GO_REF:0000024 mitochondrial fission ISS UniProtKB:O00429 1600115 GO_REF:0000024 UniProt GO_REF:0000024 mitochondrial fission ISO RGD:733618 1624291 (PMID:23349293), (PMID:23530241), (PMID:23921378), (PMID:26992161), (PMID:27145208) RGD PMID:23349293 more ... mitochondrial fragmentation involved in apoptotic process IMP 12738363 RGD mitochondrial fragmentation involved in apoptotic process IBA PANTHER:PTN002480309 more ... 13792537 PMID:21873635 GO_Central mitochondrial fragmentation involved in apoptotic process ISO RGD:733618 1624291 (PMID:12499352), (PMID:18353969), (PMID:21149567) RGD PMID:12499352 more ... mitochondrial membrane fission ISO RGD:733618 1624291 (PMID:11514614), (PMID:27301544), (PMID:27328748) RGD PMID:11514614 more ... mitochondrion morphogenesis ISO RGD:733618 1624291 (PMID:21149567) RGD PMID:21149567 mitochondrion morphogenesis IMP 7800727 RGD mitochondrion organization ISO RGD:733618 1624291 (PMID:11514614) RGD PMID:11514614 mitochondrion organization ISO RGD:733619 1624291 MGI:MGI:5312923 (MGI:MGI:6142037 , PMID:28063983) RGD MGI:MGI:6142037 , PMID:28063983 necroptotic process ISO RGD:733618 1624291 (PMID:22265414) RGD PMID:22265414 necroptotic process ISS UniProtKB:O00429 1600115 GO_REF:0000024 UniProt GO_REF:0000024 necroptotic process ISO RGD:733619 1624291 (MGI:MGI:5516181, PMID:22265414) RGD MGI:MGI:5516181 , PMID:22265414 negative regulation of mitochondrial fusion IMP 12793033 PMID:23792689 CAFA organelle fission IBA FB:FBgn0026479 more ... 13792537 PMID:21873635 GO_Central peroxisome fission ISO RGD:733618 1624291 (PMID:12618434), (PMID:18353969), (PMID:23921378) RGD PMID:12618434 more ... peroxisome fission ISS UniProtKB:O00429 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of apoptotic process ISO RGD:733618 1624291 (PMID:20850011) RGD PMID:20850011 positive regulation of dendritic spine morphogenesis IMP 7800727 RGD positive regulation of intrinsic apoptotic signaling pathway ISO RGD:733618 1624291 (PMID:20850011) RGD PMID:20850011 positive regulation of mitochondrial fission IMP 12738363 RGD positive regulation of mitochondrial fission ISO RGD:733618 1624291 (PMID:19279012) RGD PMID:19279012 positive regulation of neutrophil chemotaxis ISO RGD:733618 1624291 (PMID:28388446) RGD PMID:28388446 positive regulation of protein secretion ISO RGD:733618 1624291 (PMID:9570752) RGD PMID:9570752 positive regulation of release of cytochrome c from mitochondria ISO RGD:733618 1624291 (PMID:21149567) RGD PMID:21149567 positive regulation of synaptic vesicle endocytosis IMP 12793033 PMID:23792689 CAFA positive regulation of synaptic vesicle exocytosis IMP 12793033 PMID:23792689 CAFA protein complex oligomerization ISO RGD:733618 1624291 (PMID:27145208) RGD PMID:27145208 protein complex oligomerization ISS UniProtKB:O00429 1600115 GO_REF:0000024 UniProt GO_REF:0000024 protein localization to mitochondrion ISO RGD:733619 1624291 (MGI:MGI:5562573, PMID:24515348) RGD MGI:MGI:5562573 , PMID:24515348 protein-containing complex assembly ISO RGD:733618 1624291 (PMID:20850011) RGD PMID:20850011 regulation of ATP metabolic process ISO RGD:733619 1624291 (MGI:MGI:4459561, PMID:20585624) RGD MGI:MGI:4459561 , PMID:20585624 regulation of autophagy of mitochondrion ISO RGD:733618 1624291 UniProtKB:Q9BXM7 (PMID:19279012) RGD PMID:19279012 regulation of autophagy of mitochondrion IBA PANTHER:PTN002480309 , UniProtKB:O00429 13792537 PMID:21873635 GO_Central regulation of gene expression ISO RGD:733619 1624291 MGI:MGI:5312923 (MGI:MGI:6142037 , PMID:28063983) RGD MGI:MGI:6142037 , PMID:28063983 regulation of mitochondrion organization ISO RGD:733618 1624291 (PMID:18353969), (PMID:21149567) RGD PMID:18353969 , PMID:21149567 regulation of mitochondrion organization IBA FB:FBgn0026479 more ... 13792537 PMID:21873635 GO_Central regulation of mitochondrion organization ISO RGD:733619 1624291 (MGI:MGI:4459561, PMID:20585624) RGD MGI:MGI:4459561 , PMID:20585624 regulation of peroxisome organization ISO RGD:733618 1624291 (PMID:18353969) RGD PMID:18353969 regulation of peroxisome organization ISO RGD:733619 1624291 (MGI:MGI:4459561, PMID:20585624) RGD MGI:MGI:4459561 , PMID:20585624 regulation of ubiquitin protein ligase activity ISO RGD:733619 1624291 MGI:MGI:5312923 (MGI:MGI:6142037 , PMID:28063983) RGD MGI:MGI:6142037 , PMID:28063983 release of cytochrome c from mitochondria ISO RGD:733618 1624291 (PMID:20850011) RGD PMID:20850011 response to flavonoid IEP 12738213 dihydromyricetin RGD response to hypobaric hypoxia IEP 12738213 RGD rhythmic process IEA UniProtKB-KW:KW-0090 1600115 GO_REF:0000043 UniProt GO_REF:0000043 synaptic vesicle endocytosis IDA 12793033 PMID:23792689 SynGO synaptic vesicle endocytosis IMP 12793033 PMID:23792689 SynGO synaptic vesicle recycling via endosome IMP 12793033 PMID:23792689 CAFA Cellular Component brush border ISO RGD:733619 1624291 (MGI:MGI:5621262, PMID:22114352) RGD MGI:MGI:5621262 , PMID:22114352 clathrin coat of trans-Golgi network vesicle NOT IDA 11535088 PMID:9472031 ParkinsonsUK-UCL clathrin-coated pit colocalizes_with IDA 12793033 PMID:23792689 CAFA cytoplasm ISO RGD:733619 1624291 (MGI:MGI:5514296, PMID:23798729) RGD MGI:MGI:5514296 , PMID:23798729 cytoplasm IBA CGD:CAL0000188111 more ... 13792537 PMID:21873635 GO_Central cytoplasm ISO RGD:733618 1624291 (PMID:12618434), (PMID:21149567), (PMID:23349293), (PMID:28969390) RGD PMID:12618434 more ... cytosol IDA 1357948 RGD cytosol ISS UniProtKB:Q8K1M6 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cytosol ISS UniProtKB:O00429 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cytosol IDA 11535088 PMID:9472031 ParkinsonsUK-UCL cytosol ISO RGD:733618 1624291 (PMID:11514614), (PMID:22265414), (PMID:23921378) RGD GO_REF:0000052 more ... cytosol ISO RGD:733619 1624291 (MGI:MGI:5508698 more ... RGD MGI:MGI:5508698 more ... endoplasmic reticulum NOT ISO RGD:733618 1624291 (PMID:11514614) RGD PMID:11514614 endoplasmic reticulum ISO RGD:733618 1624291 (PMID:9472031) RGD PMID:9472031 endoplasmic reticulum IDA 11535088 PMID:9472031 ParkinsonsUK-UCL Golgi apparatus ISO RGD:733618 1624291 (PMID:20688057) RGD PMID:20688057 Golgi membrane IDA 11535088 PMID:9472031 ParkinsonsUK-UCL intracellular membrane-bounded organelle IDA 1357948 RGD intracellular membrane-bounded organelle ISO RGD:733618 1624291 RGD GO_REF:0000052 membrane IBA FB:FBgn0003392 more ... 13792537 PMID:21873635 GO_Central microtubule ISO RGD:733618 1624291 (PMID:21525035) RGD PMID:21525035 microtubule colocalizes_with ISO RGD:733618 1624291 (PMID:9472031) RGD PMID:9472031 microtubule cytoskeleton ISO RGD:733619 1624291 (MGI:MGI:5514296, PMID:23798729) RGD MGI:MGI:5514296 , PMID:23798729 mitochondrial membrane colocalizes_with IDA 12793033 PMID:23792689 CAFA mitochondrial outer membrane ISO RGD:733619 1624291 (MGI:MGI:4881586 more ... RGD MGI:MGI:4881586 more ... mitochondrial outer membrane ISS UniProtKB:Q8K1M6 1600115 GO_REF:0000024 UniProt GO_REF:0000024 mitochondrial outer membrane ISS UniProtKB:O00429 1600115 GO_REF:0000024 UniProt GO_REF:0000024 mitochondrial outer membrane ISO RGD:733618 1624291 (PMID:21149567), (PMID:26122121), (PMID:27145208) RGD PMID:21149567 more ... mitochondrion IDA 1357948 RGD mitochondrion ISO RGD:733619 1624291 (MGI:MGI:5508698 more ... RGD MGI:MGI:5508698 more ... mitochondrion ISS UniProtKB:Q8K1M6 1600115 GO_REF:0000024 UniProt GO_REF:0000024 mitochondrion ISS UniProtKB:O00429 1600115 GO_REF:0000024 UniProt GO_REF:0000024 mitochondrion ISO RGD:733618 1624291 (PMID:11514614), (PMID:22265414), (PMID:23349293), (PMID:23530241), (PMID:23921378), (PMID:24599962), (PMID:26618722), (PMID:28969390), (PMID:29307555) RGD PMID:11514614 more ... mitochondrion-derived vesicle colocalizes_with ISO RGD:733618 1624291 (PMID:26618722) RGD PMID:26618722 perinuclear region of cytoplasm ISO RGD:733618 1624291 (PMID:9472031), (PMID:9570752) RGD PMID:9472031 , PMID:9570752 perinuclear region of cytoplasm IDA 11535088 PMID:9472031 ParkinsonsUK-UCL peroxisome IDA 1357948 RGD peroxisome ISS UniProtKB:O00429 1600115 GO_REF:0000024 UniProt GO_REF:0000024 peroxisome ISO RGD:733618 1624291 (PMID:12618434), (PMID:23921378) RGD PMID:12618434 , PMID:23921378 plasma membrane NOT IDA 11535088 PMID:9472031 ParkinsonsUK-UCL presynaptic endocytic zone membrane IDA 12793033 PMID:23792689 SynGO protein-containing complex ISO RGD:733618 1624291 (PMID:17408615), (PMID:18353969) RGD PMID:17408615 , PMID:18353969 secretory vesicle IDA 11535088 PMID:9472031 ParkinsonsUK-UCL synaptic vesicle membrane IDA 12793033 PMID:23792689 SynGO Molecular Function BH2 domain binding IPI UniProtKB:P53563 12793033 PMID:23792689 CAFA clathrin binding IPI UniProtKB:P08081 12793033 PMID:23792689 CAFA GTP binding IEA UniProtKB-KW:KW-0342 1600115 GO_REF:0000043 UniProt GO_REF:0000043 GTP-dependent protein binding ISO RGD:733618 1624291 (PMID:25767741) RGD PMID:25767741 GTPase activity ISO RGD:733618 1624291 (PMID:22265414), (PMID:23530241) RGD PMID:22265414 , PMID:23530241 GTPase activity IBA PANTHER:PTN000170013 more ... 13792537 PMID:21873635 GO_Central GTPase activity ISS UniProtKB:O00429 1600115 GO_REF:0000024 UniProt GO_REF:0000024 identical protein binding IPI RGD:620416 12738215 homooligomerization RGD identical protein binding ISO RGD:733618 1624291 UniProtKB:O00429 more ... RGD PMID:18353969 more ... lipid binding IEA UniProtKB-KW:KW-0446 1600115 GO_REF:0000043 UniProt GO_REF:0000043 microtubule binding IBA FB:FBgn0003392 , PANTHER:PTN000170013 13792537 PMID:21873635 GO_Central protein binding IPI UniProtKB:Q4KM98 12793033 PMID:23792689 CAFA protein binding ISO RGD:733619 1624291 PR:Q9WVS6 more ... RGD MGI:MGI:5431272 more ... protein binding ISO RGD:733618 1624291 UniProtKB:P03372 more ... RGD PMID:12861026 more ... protein binding IPI UniProtKB:P53563-1 12793033 PMID:23792689 IntAct protein binding IPI UniProtKB:P53563-1 8553310 PMID:18250306 IntAct protein homodimerization activity ISO RGD:733618 1624291 (PMID:22265414), (PMID:23530241) RGD PMID:22265414 , PMID:23530241 protein homodimerization activity ISS UniProtKB:O00429 1600115 GO_REF:0000024 UniProt GO_REF:0000024 protein homodimerization activity ISO RGD:733619 1624291 (MGI:MGI:4459561, PMID:20585624) RGD MGI:MGI:4459561 , PMID:20585624 protein-containing complex binding IPI RGD:1310230 more ... 12793033 RGD Rab GTPase binding ISO RGD:733618 1624291 (PMID:25767741) RGD PMID:25767741 ubiquitin protein ligase binding ISO RGD:733618 1624291 UniProtKB:Q969V5 , UniProtKB:Q9NX47 (PMID:16874301), (PMID:19407830) RGD PMID:16874301 , PMID:19407830
Gene-Chemical Interaction Annotations
